Spectrum-X

Hewlett Packard Enterprise Debuts End-to-End AI-Native Portfolio for Generative AI

Retrieved on: 
Monday, March 18, 2024

Today at NVIDIA GTC, Hewlett Packard Enterprise (NYSE: HPE) announced updates to one of the industry’s most comprehensive AI-native portfolios to advance the operationalization of generative AI (GenAI), deep learning, and machine learning (ML) applications.

Key Points: 
  • Today at NVIDIA GTC, Hewlett Packard Enterprise (NYSE: HPE) announced updates to one of the industry’s most comprehensive AI-native portfolios to advance the operationalization of generative AI (GenAI), deep learning, and machine learning (ML) applications.
  • The solution is enhanced by HPE’s machine learning platform and analytics software, NVIDIA AI Enterprise 5.0 software with new NVIDIA NIM microservice for optimized inference of generative AI models, as well as NVIDIA NeMo Retriever and other data science and AI libraries.
  • For more information or to order it today, visit HPE’s enterprise computing solution for generative AI .
  • HPE’s AI software is available on both HPE’s supercomputing and enterprise computing solutions for generative AI to provide a consistent environment for customers to manage their GenAI workloads.

Hewlett Packard Enterprise collaborates with NVIDIA to deliver an enterprise-class, full-stack GenAI solution

Retrieved on: 
Thursday, November 30, 2023

Hewlett Packard Enterprise (NYSE: HPE) announced an expanded strategic collaboration with NVIDIA to build an enterprise computing solution for generative AI (GenAI).

Key Points: 
  • Hewlett Packard Enterprise (NYSE: HPE) announced an expanded strategic collaboration with NVIDIA to build an enterprise computing solution for generative AI (GenAI).
  • The offering removes the complexity of developing and deploying GenAI infrastructure with a full-stack AI tuning and inferencing solution from HPE and NVIDIA.
  • The new enterprise computing solution for generative AI is part of an expanded collaboration between HPE and NVIDIA that delivers full-stack, out-of-the-box AI solutions.
  • The enterprise computing solution for generative AI is a smaller form-factor AI solution for enterprise customers that are focused on tuning and inferencing.

NVIDIA Launches Accelerated Ethernet Platform for Hyperscale Generative AI

Retrieved on: 
Monday, May 29, 2023

TAIPEI, Taiwan, May 28, 2023 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced NVIDIA Spectrum-X™ , an accelerated networking platform designed to improve the performance and efficiency of Ethernet-based AI clouds.

Key Points: 
  • TAIPEI, Taiwan, May 28, 2023 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced NVIDIA Spectrum-X™ , an accelerated networking platform designed to improve the performance and efficiency of Ethernet-based AI clouds.
  • NVIDIA Spectrum-X is built on networking innovations powered by the tight coupling of the NVIDIA Spectrum-4 Ethernet switch with the NVIDIA BlueField®-3 DPU , achieving 1.7x better overall AI performance and power efficiency, along with consistent, predictable performance in multi-tenant environments.
  • As a blueprint and testbed for NVIDIA Spectrum-X reference designs, NVIDIA is building Israel-1, a hyperscale generative AI supercomputer to be deployed in its Israeli data center on Dell PowerEdge XE9680 servers based on the NVIDIA HGX™ H100 eight-GPU platform , BlueField-3 DPUs and Spectrum-4 switches.
  • “NVIDIA Spectrum-X is a new class of Ethernet networking that removes barriers for next-generation AI workloads that have the potential to transform entire industries.”
    The NVIDIA Spectrum-X networking platform is highly versatile and can be used in various AI applications.

SpectrumX Strengthens Senior Leadership

Retrieved on: 
Tuesday, June 21, 2022

SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant and Greg Whelan being appointed as Group Sales Director.

Key Points: 
  • SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce it has strengthened its senior management team with Dr Donna Lockhart joining as Head of Medicines consultant and Greg Whelan being appointed as Group Sales Director.
  • Greg Whelans career in the healthcare sector spans over 20 years with senior sales positions at blue-chip organisations such as GlaxoSmithKline, MSD and Omnicell as well as SME consultancies.
  • Dr Donna Lockhart, Head of Medicines at SpectrumX, added: SpectrumX is developing innovative solutions to illnesses within the medical sphere and it is exciting to join such a progressive company.
  • Greg Whelan, Group Sales Director at SpectrumX, commented: I am delighted to join the team at SpectrumX at this pivotal time as it approaches the commercial launch of its consumer HOCI-based products.